v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Jun. 30, 2020
Current assets:    
Cash $ 73,181 $ 197,622
Accounts receivable (net of allowance of $0 and $0, respectively) 44,033 61,013
Inventory 344,914 275,605
Other current asset 251,752 398,085
Total current assets 713,880 932,325
Total assets 723,880 932,325
Current liabilities:    
Accounts payable 1,393,256 1,286,149
Accrued expense - related party 9,974 9,974
Fair value of derivative liabilities 1,312,177 1,590,638
Convertible notes payable - net of discounts 2,077,852 2,330,189
Accrued expenses 72,044  
Accrued interest 209,161 192,625
Short-term borrowings- line of credit 589 3,897
Total current liabilities 5,075,053 5,413,472
Commitments and contingencies
Stockholders’ deficit:    
Preferred stock, ($0.001 par value, 100,000,000 shares authorized, and 1,000 issued and outstanding as of March 31, 2021 and 1,000 outstanding as of June 30, 2020, respectively) 1 1
Common stock, without par value, 200,000,000 shares authorized, and 78,685,171 issued and outstanding as of March 31, 2021 and 61,796,680 outstanding as of June 30, 2020, respectively 78,685 61,797
Additional paid in capital 16,683,505 13,088,177
Accumulated deficit (21,084,364) (17,631,122)
Total stockholders’ deficit (4,342,173) (4,481,147)
Total Liabilities and Stockholders’ Deficit $ 713,880 $ 932,325

Source